Yunpi Xiefei Huatan Tang decoction reduces airway inflammation and airway remodeling in asthmatic mice through Wnt/β-catenin signaling pathway
Main Article Content
Keywords
airway inflammation, airway remodeling, asthma, Wnt/β-catenin pathway, Yunpi Xiefei Huatan Tang decoction
Abstract
Background: Asthma is one of the most prevalent chronic respiratory diseases among children, markedly impairing patient’s health and imposing an increasing burden on the healthcare system. Several traditional Chinese medicines have demonstrated efficacy in alleviating asthma symptoms through studies conducted on animal models. Recent studies have shown that the Yunpi Xiefei Huatan Tang decoction (YPD) exhibits significant therapeutic outcomes in treating phlegm-obstructed pulmonary asthma. However, the precise regulatory effects of YPD on the progression of asthma require additional investigation.
Objective: To explore the functions of YPD in asthma progression.
Material and Methods: The asthma rat model triggered by ovalbumin (OVA) was established successfully. The pathological changes of lung tissues were examined through Hematoxylin and Eosin (H&E) staining. The levels of Interleukin 6 (IL-6) and IL-1β were tested through Enzyme-Linked-Immunosorbent Serologic Assay (ELISA). The number of total cells or eosinophils in bronchoalveolar lavage fluid was confirmed through cell counter. The collagen deposition in bronchi was assessed through Masson staining. The protein expressions were measured through western blot.
Results: This study demonstrated that YPD could mitigate airway inflammation in an OVA-triggered asthma rat model. Furthermore, YPD was found to decrease the production of inflammatory cytokines in the lungs and suppress the infiltration of inflammatory cells into bronchoalveolar lavage fluid. Additionally, the airway remodeling stimulated by OVA could be suppressed following YPD treatment. Finally, it was disclosed that YPD inhibited the wingless-related integration site–beta-catenin (Wnt/β-catenin) signaling pathway in the OVA-stimulated asthma rat model.
Conclusion: YPD alleviated airway inflammation and remodeling in asthmatic mice via the Wnt/β-catenin signaling pathway. This research offers significant insights into the potential application of YPD in the treatment of asthma.
References
2 Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45–56. 10.1038/ni.3049
3 Castillo JR, Peters SP, Busse WW. Asthma exacerbations: Pathogenesis, prevention, and treatment. J Allergy Clin Immunol Pract. 2017;5(4):918–27. 10.1016/j.jaip.2017.05.001
4 Ardura-Garcia C, Mallet MC, Berger DO, Hoyler K, Jochmann A, Kuhn A, et al. Predictors of asthma control differ from predictors of asthma attacks in children: The Swiss Paediatric Airway Cohort. Clin Exp Allergy. 2023;53(11):1177–86. 10.1111/cea.14390
5 Savin IA, Zenkova MA, Sen’kova AV. Bronchial asthma, airway remodeling and lung fibrosis as successive steps of one process. Int J Mol Sci. 2023;24(22):16042. 10.3390/ijms242216042
6 Aguilar D, Bosacoma A, Blanco I, Tura-Ceide O, Serrano-Mollar A, Barberà JA, et al. Differences and similarities between the lung transcriptomic profiles of COVID-19, COPD, and IPF patients: A meta-analysis study of pathophysiological signaling pathways. Life (Basel). 2022;12(6):887. 10.3390/life12060887
7 Deimel LP, Li Z, Ranasinghe C. Interleukin-13 as a target to alleviate severe coronavirus disease 2019 and restore lung homeostasis. J Clin Transl Res. 2021;7(1):116–20.
8 Ora J, Calzetta L, Matera MG, Cazzola M, Rogliani P. Advances with glucocorticoids in the treatment of asthma: State of the art. Expert Opin Pharmacother. 2020;21(18):2305–16. 10.1080/14656566.2020.1807514
9 Yan Y, Liu L, Dou Z, Xu Y, Yan X. Soufeng Yuchuan decoction mitigates the ovalbumin-induced lung damage in a rat model of asthma. Biomed Pharmacother. 2020;125:109933. 10.1016/j.biopha.2020.109933
10 Pan LY, Han YQ, Wang YZ, Chen QQ, Wu Y, Sun Y. Mechanism of Yanghe Pingchuan granules treatment for airway remodeling in asthma. Drug Des Devel Ther. 2018;12:1941–51. 10.2147/DDDT.S159428
11 Luo J, Zhang L, Zhang X, Long Y, Zou F, Yan C, et al. Protective effects and active ingredients of Salvia miltiorrhiza Bunge extracts on airway responsiveness, inflammation and remodeling in mice with ovalbumin-induced allergic asthma. Phytomedicine. 2019;52:168–77. 10.1016/j.phymed.2018.09.170
12 Zhang C, Zhang LH, Wu YF, Lai TW, Wang HS, Xiao H, et al. Suhuang antitussive capsule at lower doses attenuates airway hyperresponsiveness, inflammation, and remodeling in a murine model of chronic asthma. Sci Rep. 2016;6:21515. 10.1038/srep21515
13 Qian K, Xu H, Chen Z, Zheng Y. Advances in pulmonary rehabilitation for children with bronchial asthma. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023;52(4):518–25. 10.3724/zdxbyxb-2023-0081
14 Zampogna E, Spanevello A, Visca D. Pulmonary rehabilitation: Promising nonpharmacological approach for treating asthma? Curr Opin Allergy Clin Immunol. 2020;20(1):80–4. 10.1097/ACI.0000000000000597
15 Tattersall MC, Jarjour NN, Busse PJ. Systemic inflammation in asthma: What are the risks and impacts outside the airway? J Allergy Clin Immunol Pract. 2024;12(4):849–62. 10.1016/j.jaip.2024.02.004
16 Yi L, Cui J, Wang W, Tang W, Teng F, Zhu X, et al. Formononetin attenuates airway inflammation and oxidative stress in murine allergic asthma. Front Pharmacol. 2020;11:533841. 10.3389/fphar.2020.533841
17 Zhou DG, Diao BZ, Zhou W, Feng JL. Oroxylin A inhibits allergic airway inflammation in ovalbumin (OVA)-induced asthma murine model. Inflammation. 2016;39(2):867–72. 10.1007/s10753-016-0317-3
18 Yu B, Cai W, Zhang HH, Zhong YS, Fang J, Zhang WY, et al. Selaginella uncinata flavonoids ameliorated ovalbumin-induced airway inflammation in a rat model of asthma. J Ethnopharmacol. 2017;195:71–80. 10.1016/j.jep.2016.11.049
19 Jung CJ, Park SM, Lee DG, Yu YE, Ku TH, La IJ, et al. Adenophora stricta root extract alleviates airway inflammation in mice with ovalbumin-induced allergic asthma. Antioxidants (Basel). 2023;12(4):922. 10.3390/antiox12040922
20 Varricchi G, Brightling CE, Grainge C, Lambrecht BN, Chanez P. Airway remodelling in asthma and the epithelium: On the edge of a new era. Eur Respir J. 2024;63(4):2301619. 10.1183/13993003.01619-2023
21 Britt RD, Jr., Ruwanpathirana A, Ford ML, Lewis BW. Macrophages Orchestrate Airway Inflammation, Remodeling, and Resolution in Asthma. Int J Mol Sci. 2023;24(13). 10.3390/ijms241310451
22 Fang Y, Jin W, Guo Z, Hao J. Quercetin alleviates asthma-induced airway inflammation and remodeling through downregulating periostin via blocking TGF-β1/Smad pathway. Pharmacology. 2023;108(5):432–43. 10.1159/000530703
23 Huang D, Sun C, Chen M, Bai S, Zhao X, Wang W, et al. Bergenin ameliorates airway inflammation and remodeling in asthma by activating SIRT1 in macrophages to regulate the NF-κB pathway. Front Pharmacol. 2022;13:994878. 10.3389/fphar.2022.994878
24 Chen X, Xiao Z, Jiang Z, Jiang Y, Li W, Wang M. Schisandrin B attenuates airway inflammation and airway remodeling in asthma by inhibiting NLRP3 inflammasome activation and reducing pyroptosis. Inflammation. 2021;44(6):2217–31. 10.1007/s10753-021-01494-z
25 Huang Y, Wang L, Jia XX, Lin XX, Zhang WX. Vitamin D alleviates airway remodeling in asthma by down-regulating the activity of Wnt/β-catenin signaling pathway. Int Immunopharmacol. 2019;68:88–94. 10.1016/j.intimp.2018.12.061
26 Yang X, Lv JN, Li H, Jiao B, Zhang QH, Zhang Y, et al. Curcumin reduces lung inflammation via Wnt/β-catenin signaling in mouse model of asthma. J Asthma. 2017;54(4):335–40. 10.1080/02770903.2016.1218018
27 Yuan Y, Zhu H, Huang S, Zhang Y, Shen Y. SFRP5 partially inhibits the proliferation and migration of airway smooth muscle cells in children with asthma by regulating the Wnt/β-catenin signaling pathway. Discov Med. 2024;36(181):323–31. 10.24976/Discov.Med.202436181.30
28 Song J, Zhu XM, Wei QY. MSCs reduce airway remodeling in the lungs of asthmatic rats through the Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(21):11199–211.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.